- Friday, June 1: Maria Moroni, PhD, Research Associate (Henry M. Jackson Foundation), Radiation Countermeasures Program, AFRRI: Efficacy of G-CSF administration and identification of an accelerated bone marrow syndrome in a minipig model of ARS. Related information:
- Friday, May 18: Xinyue Lu, MD, PhD, Research Scientist (Henry M. Jackson Foundation), Radiation Countermeasures Program, AFRRI: Radioprotective effect of 17-DMAG in mice. Related Information:
- Friday, May 11:
Zheng Wang, PhD, Research Biologist, Naval Research Laboratory, Washington, DC: Transcriptomic analysis reveals adaptation of the black yeast to the low dose of ionizing radiation. Related information:
- Friday, April 27: Kushal Chakraborty, PhD, Staff Investigator (Henry M. Jackson Foundation), Radiation Countermeasures Program, AFRRI: Combined effect of GT3 and simvastatin on radiation induced hematopoietic injury. Related information:
- Friday, April 20: Gregory L. King, PhD, Research Physiologist,
Radiation Countermeasures Program, AFRRI: Acute response to space radiation: Prodromal syndrome in ferrets. Related information:
- Friday, April 13: Risaku Fukumoto, PhD, Research Associate, Henry M. Jackson Foundation (Radiation Combined Injury Program, AFRRI): Ciprofloxacin: Not just an antimicrobial. Related information:
- Friday, April 6: Cam T. Ha, PhD, Research Scientist, Henry M. Jackson Foundation (Radiation Countermeasures Program, AFRRI): Genistein inhibits radiation-induced inflammation and protects mouse hematopoietic tissue. Related information:
- Friday, March 30: Thomas B. Elliott, PhD, Research Microbiologist, Combined Injury Program, AFRRI: Procalcitonin as a biomarker to detect radiation-induced sepsis in mice and to monitor therapy. Related information:
- Friday, March 16: Mark H. Whitnall, PhD, Program Advisor, Radiation Countermeasures Program, AFRRI: Gottingen minipig model of acute radiation syndrome (ARS). Related information:
- Friday, March 9: Lynnette Cary, PhD, Staff Scientist (Henry M. Jackson Foundation), Radiation Countermeasures Program, AFRRI: Endothelial cell regulation of hematopoietic cells after radiation injury. Related information:
- Friday, March 2: Michael R. Landauer, PhD, Research Toxicologist, AFRRI: Isoflavone-induced radiation protection: Current status. Related information:
-
Friday, February 24: William F. Blakely, PhD, Program Advisor, Biological Dosimetry, AFRRI: Update on translational biodosimetry research activities. Related information:
- Friday, February 17: Joel Lowy, PhD, Principal Investigator, AFRRI: Responses of innate immune system cells to combined exposure to radiation and PAMPs.
- Friday, February 10: Natalia I. Ossetrova, PhD, Research Biologist, Biological Dosimetry Program, AFRRI: Further evaluation of combined proteomic and hematological approach for biodosimetry applications. Related information:
- Friday, February 3: MAJ Eric D. Lombardini, VMD, Chief, Division of Comparative Pathology, Veterinary Sciences Department, AFRRI: Tissue collection for histopathology in various laboratory species. Related information:
- Friday, January 13: Juliann G. Kiang, PhD, Senior Principal Investigator, Combined Injury Program, AFRRI: Ciprofloxacin as a drug to treat radiation combined injury. Related information:
- Geldanamycin analog 17-DMAG limits apoptosis in human peripheral blood cells by inhibition of p53 activation and its interaction with heat shock protein 90 kDa after ionizing radiation. Radiat Res., 176:333–345, 2011.
- Radiation combined injury: DNA damage, apoptosis, and autophagy. Adapt Med., 2:1–10, 2010.
- Wound trauma increases radiation-induced mortality by increasing iNOS, cytokine concentrations, and bacterial infections. Radiate Res., 173:319–332, 2010.
- Friday, January 20: Nikolai Gorbunov, PhD, Henry M. Jackson Foundation (Combined Injury Program, AFRRI), Bethesda, MD: Response of mouse mesenchymal stromal cells (MSCs) to challenge with Escherichia coli: A proposed defense role of MSCs in the tissue barriers. Related information:
|